A Range of Risk | GenomeWeb

A Range of Risk

Personalized genetic tests may be flawed and have few health benefits, reports Ian Sample at the Guardian. Researchers from Erasmus University Medical Center in Rotterdam, the Netherlands, simulated genetic data from 100,000 people and then used 23andMe and DecodeMe's formulas to predict the risk of eight health conditions for that simulated population.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.